Literature DB >> 6829656

A prospective, controlled study of maternal and perinatal outcome after intra-amniotic infection at term.

P R Yoder, R S Gibbs, J D Blanco, Y S Castaneda, P J St Clair.   

Abstract

A study was made of the outcome for mothers and their neonates with both clinical and bacteriologic evidence of intra-amniotic infection at term. Samples of amniotic fluid from patients with intra-amniotic infection showed greater than 10(2) colony-forming units per milliliter of a high-virulence isolate, whereas samples from control patients showed no growth or low-virulence isolates only. Control patients were uninfected during labor and were matched on the basis of gestational age, interval from rupture of membranes to delivery, and mode of delivery. There were 67 matched pairs. The mean interval from diagnosis of intra-amniotic infection to delivery was 3.1 +/- 2.2 hours (+/- SD). Mothers with intra-amniotic infection had a significantly longer hospital stay and greater fever index after delivery than did control patients. Intrapartum bacteremia was documented in six of 50 (12%) women with intra-amniotic infection. The cesarean birth rate was 36%. There was one case of probable septic shock and one of postpartum hemorrhage among women with intra-amniotic infection. Infants in the intra-amniotic infection group had a significantly longer hospital stay than did the control infants. Among 59 infants for whom blood culture results were available, bacteremia was documented in five (8%) with intra-amniotic infection. Definite radiographic evidence of pneumonia was present in 4%; there were no cases of meningitis. There was one perinatal death in the intra-amniotic infection group. Overall, the maternal and perinatal outcome after intra-amniotic infection at term was excellent.

Entities:  

Mesh:

Year:  1983        PMID: 6829656     DOI: 10.1016/0002-9378(83)90575-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

1.  Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.

Authors:  Roberto Romero; Jezid Miranda; Juan P Kusanovic; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Alicia Martinez; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Majid Shaman; Kia Lannaman; Bo Hyun Yoon; Sonia S Hassan; Chong J Kim; Steven J Korzeniewski; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2015-01       Impact factor: 1.901

2.  Clinical chorioamnionitis at term IX: in vivo evidence of intra-amniotic inflammasome activation.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Eli Maymon; Juan Pedro Kusanovic; Bogdan Panaitescu; Derek Miller; Percy Pacora; Adi L Tarca; Kenichiro Motomura; Offer Erez; Eunjung Jung; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

3.  Transplacental transfer of cefuroxime in uncomplicated pregnancies and those complicated by hydrops or changes in amniotic fluid volume.

Authors:  D E Holt; N M Fisk; J A Spencer; J de Louvois; R Hurley; D Harvey
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

4.  Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile.

Authors:  Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Zhong Dong; Noppadol Chaiyasit; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

5.  Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity.

Authors:  Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Juan P Kusanovic; Bo Hyun Yoon; Jung-Sun Kim; Noppadol Chaiyasit; Ahmed I Ahmed; Faisal Qureshi; Suzanne M Jacques; Chong Jai Kim; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

Review 6.  Diagnosis and management of clinical chorioamnionitis.

Authors:  Alan T N Tita; William W Andrews
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

7.  Clinical Chorioamnionitis at Term: New Insights into the Etiology, Microbiology, and the Fetal, Maternal and Amniotic Cavity Inflammatory Responses.

Authors:  Roberto Romero; Nardhy Gomez-Lopez; Juan Pedro Kusanovic; Percy Pacora; Bogdan Panaitescu; Offer Erez; Bo Hyun Yoon
Journal:  Nogyogyaszati Szuleszeti Tovabbkepzo Szemle       Date:  2018-06

8.  Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation.

Authors:  Kyung Joon Oh; Sun Min Kim; Joon-Seok Hong; Eli Maymon; Offer Erez; Bogdan Panaitescu; Nardhy Gomez-Lopez; Roberto Romero; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2017-02-28       Impact factor: 8.661

9.  Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response.

Authors:  Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Adi L Tarca; Gaurav Bhatti; Zhonghui Xu; Juan P Kusanovic; Noppadol Chaiyasit; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

10.  Clinical chorioamnionitis at term VIII: a rapid MMP-8 test for the identification of intra-amniotic inflammation.

Authors:  Noppadol Chaiyasit; Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Gaurav Bhatti; Juan Pedro Kusanovic; Zhong Dong; Lami Yeo; Percy Pacora; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2017-07-26       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.